肌张力障碍
帕金森病
先证者
外显率
GTP环水解酶I
运动障碍
家族史
遗传学
无症状携带者
左旋多巴
医学
突变
无症状的
基因
疾病
生物
内科学
精神科
帕金森病
四氢生物蝶呤
一氧化氮
表型
一氧化氮合酶
作者
Carolina Pereira de Souza Melo,Eugênia Ribeiro Valadares,Amelia Trindade,Vega Rocha,Luiz Roberto de Oliveira,Ana Lúcia Brunialti Godard
摘要
Dopa-responsive dystonia (DRD), also known as Segawa syndrome or hereditary progressive dystonia with diurnal fluctuation, is clinically characterized by the occurrence of simultaneous or late Parkinsonism and by an excellent response to treatment with low doses of L-dopa. Diagnosis of DRD is essentially clinical. It is based on clinical history and the response to treatment with low doses of L-dopa. However, due to the low penetrance of the disease, asymptomatic carriers may exist. In these cases, mutational analysis of the GCH1 gene is an alternative to diagnose DRD. In the present study, we investigated a large DRD-carrier family in an attempt to identify the disease-causing mutation. The proband, a young woman diagnosed at the age of 13 years, is the daughter of a healthy non-consanguineous couple with history of several cases, on the maternal side of the family, of tip-toeing, disturbance of gait, Parkinsonism, rigidity and cramps in the lower limbs. Using single strand conformational polymorphism and DNA sequencing techniques to analyze DNA extracted from blood samples, we identified a mutation in the GCH1 gene, IVS5+3insT, which would preclude the formation of the active enzyme due to the formation of truncated peptides.
科研通智能强力驱动
Strongly Powered by AbleSci AI